We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Researchers Add 18 Organisms to Sequencing List

By Biotechdaily staff writers
Posted on 23 Aug 2004
As part of its ongoing contribution toward the understanding of the human genome, the U.S. More...
National Human Genome Research Institute (NHGR, Bethesda, MD, USA) has announced it will begin sequencing 18 strategically selected organisms.

The first group consists of nine mammals, important for their position on the evolutionary tree. Seven of these will be used primarily to identify features that are similar among the genomes of humans: the savannah elephant, European common shrew, European hedgehog, the guinea pig, the lesser hedgehog tenrec, the nine-banded armadillo, and the rabbit. An eighth mammal, the domestic cat, was selected because of its importance as a medical model for studying disease. The ninth mammal is the orangutan, a primate that is most closely related to humans. The orangutan genome will be used to identify those features in the human genome that differ among primates.

The second group includes nine nonmallalian organisms, each of which represents a position on the evolutionary timeline marked by important changes. These comprise slime mold, a ciliate, a choanoflagellate, a placozoan, a cnidarian, a snail, two roundworms, and the lamprey.

"Science tells us that the most effective approach we currently have to identify the essential functional and structural components of our own genome is to compare it with the genomes of other organisms,” explained Mark S. Guyer, Ph.D., director of NHGRI's Division of Extramural Research. "We hope to accelerate that process with our new sequencing strategy that identifies the organisms, or sets of organisms, with the greatest potential to fill gaps in our knowledge.”




Related Links:
NHGRI

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.